- Related questions:
-- Does re-excision typically change reconstruction options?
-- In the setting of an "unidentifiable" margin, how do you consider the spectrum of a PMRT boost volume from whole chest wall boost to scar boost?
- Other details of case: Age < 50 y/o, pre-menopausal, sentinel node biopsy with pN1mic (1 of 2 examined nodes), ER/PR-positive, Her2-negative, Grade 2, negative for LVSI, declined adjuvant chemotherapy, plan for adjuvant endocrine therapy +/- ovarian ablation, no germline mutations, no Oncotype score. Patient had immediate tissue expander with plan for delayed autologous reconstruction.